108 related articles for article (PubMed ID: 10385922)
1. Effect of local intracerebral administration of EMD 57445, a selective sigma receptor ligand, on the locomotor activity of the rat.
Skuza G; Kolasiewicz W; Dziedzicka-Wasylewska M; Margas W
Pol J Pharmacol; 1998; 50(6):399-406. PubMed ID: 10385922
[TBL] [Abstract][Full Text] [Related]
2. Effect of EMD 57445, the selective sigma receptor ligand, on the turnover and release of dopamine.
Skuza G; Gołembiowska K; Wedzony K
Pol J Pharmacol; 1998; 50(1):61-4. PubMed ID: 9662740
[TBL] [Abstract][Full Text] [Related]
3. EMD 57445, the selective sigma receptor ligand, has no effect on the 5-hydroxytryptamine system.
Skuza G; Rogóz Z; Gołembiowska K
Pol J Pharmacol; 1997; 49(6):489-93. PubMed ID: 9566054
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
Skuza G; Rogóz Z; Wieczorek A
Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
[TBL] [Abstract][Full Text] [Related]
5. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
Rouillon C; Abraini JH; David HN
Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
[TBL] [Abstract][Full Text] [Related]
7. Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D(2) receptor activation is critical but not the expression of the unconditioned response.
Dias FR; Carey RJ; Carrera MP
Brain Res; 2006 Apr; 1083(1):85-95. PubMed ID: 16530737
[TBL] [Abstract][Full Text] [Related]
8. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.
Szczepanik AM; Brougham LR; Roehr JE; Conway PG; Ellis DB; Wilmot CA
J Pharmacol Exp Ther; 1996 Aug; 278(2):913-20. PubMed ID: 8768747
[TBL] [Abstract][Full Text] [Related]
10. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
Dhir A; Kulkarni SK
Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
[TBL] [Abstract][Full Text] [Related]
11. The effect of dopamine receptor blockade in the rodent nucleus accumbens on local field potential oscillations and motor activity in response to ketamine.
Matulewicz P; Kasicki S; Hunt MJ
Brain Res; 2010 Dec; 1366():226-32. PubMed ID: 20888326
[TBL] [Abstract][Full Text] [Related]
12. NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profile.
Karbon EW; Abreu ME; Erickson RH; Kaiser C; Natalie KJ; Clissold DB; Borosky S; Bailey M; Martin LA; Pontecorvo MJ
J Pharmacol Exp Ther; 1993 May; 265(2):866-75. PubMed ID: 8388461
[TBL] [Abstract][Full Text] [Related]
13. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic regulation of orexin neurons.
Bubser M; Fadel JR; Jackson LL; Meador-Woodruff JH; Jing D; Deutch AY
Eur J Neurosci; 2005 Jun; 21(11):2993-3001. PubMed ID: 15978010
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system.
Kõks S; Volke V; Veraksits A; Rünkorg K; Sillat T; Abramov U; Bourin M; Huotari M; Männistö PT; Matsui T; Vasar E
Psychopharmacology (Berl); 2001 Nov; 158(2):198-204. PubMed ID: 11702094
[TBL] [Abstract][Full Text] [Related]
16. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?
Isacson R; Kull B; Wahlestedt C; Salmi P
Neuroscience; 2004; 124(1):33-42. PubMed ID: 14960337
[TBL] [Abstract][Full Text] [Related]
17. Neuropharmacological profile of EMD 57445, a sigma receptor ligand with potential antipsychotic activity.
Maj J; Rogóz Z; Skuza G; Mazela H
Eur J Pharmacol; 1996 Nov; 315(3):235-43. PubMed ID: 8982660
[TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys.
Katz JL; Kopajtic TA; Myers KA; Mitkus RJ; Chider M
J Pharmacol Exp Ther; 1999 Oct; 291(1):265-79. PubMed ID: 10490913
[TBL] [Abstract][Full Text] [Related]
19. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of dopamine receptors in the paraventricular nucleus of the hypothalamus of male rats induces penile erection and increases extra-cellular dopamine in the nucleus accumbens: Involvement of central oxytocin.
Succu S; Sanna F; Melis T; Boi A; Argiolas A; Melis MR
Neuropharmacology; 2007 Mar; 52(3):1034-43. PubMed ID: 17164075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
